Blog

EU Health PPP: a new era for medtech companies

Your heart has never been more important

VIP access: a proposal for a new model for embracing healthcare innovation

New training video boosts global compliance – and public confidence

In vitro diagnostics at risk: Covid-19 delays progresses towards the new European regulations

In order to keep them available to the health care system and to patients, more than 85% of IVDs will need to be updated in view of the new in vitro Diagnostic Regulation (IVDR) which is at risk due to the ongoing COVID-19 pandemic.

Improving the lives of people living with diabetes

Planning ahead – with clear data

With more than 45 million confirmed cases and more than 1 million deaths at the time of writing, the coronavirus pandemic has wreaked havoc in virtually all countries around the world.

COPD & COVID-19: Pandemic must prompt shift to connected care

For people living with chronic obstructive pulmonary disease (COPD), a long-term lung illness, COVID-19 is having a major impact.

The changing landscape of procurement practices – blog series

Blog series on value-based procurement.

The rise of the humble medical mask

The medical mask was a product once taken for granted, but now is being recognised as a vital tool for public health. From an ugly duckling to beautiful swan, the true value of a medical mask is finally appreciated. In an imaginary world, the story of the medical mask would have probably been like this: Made of paper, elastic and some plastic, I used to live a very modest life in the shadow of other important life-saving and quality-of-life-improving medical devices, like pacemakers, heart valves and knee implants. The people who used me regularly regarded me a product that would always be available in abundance at low prices. Most hospital buyers positioned me in the unglamorous 'routine quadrant' of the widely used Kraljic-grid. They were often ready to swap me, without hesitation, for the reasons of costs. And then, one day, everything changed.

The EU’s future public-private partnership for health marks a new era for medtech innovation

As European research and innovation funds extend their focus towards diagnostics, digital and medical technologies, medtech companies must be ready to engage.

AI in healthcare: Europe gets real

AI – Artificial Intelligence – sounds like another buzzword floating in the air of Brussels when we talk about future R&D priorities. There are many interpretations of what AI means, while some people are already grumbling that it’s just another fad.